Get started
Author

A. C. McDonald

Phase I and Pharmacokinetic Study of PKC412, an Inhibitor of Protein Kinase C
2001 · D. J. Propper, A. C. McDonald, et al. · Journal of Clinical Oncology · 233
Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer
2012 · R. Carruthers, L. M. Tho, et al. · Colorectal Disease · 138
A Phase I and pharmacokinetic study of LY231514, the multitargeted antifolate
1998 · AC McDonald, PA Vasey, et al. · PubMed · 83
Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer
2017 · C N Hurt, S Falk, et al. · British Journal of Cancer · 68
PDF
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma
2002 · T.R.J. Evans, G. Pentheroudakis, et al. · Annals of Oncology · 61
Induction of p53-dependent and p53-independent cellular responses by topoisomerase 1 inhibitors
1998 · AC McDonald, R Brown · British Journal of Cancer · 56
PDF
Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks.
1997 · S Senan, R Rampling, et al. · PubMed · 46
The role of imaging in the pre-operative staging and post-operative follow-up of rectal cancer
2008 · G. Low, L.M. Tho, et al. · The Surgeon · 45
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
2018 · for the European Study Group for Pancreatic Cancer, N. O. Elander, et al. · British Journal of Cancer · 35
PDF
Ampullary cancer ESPAC-3 (v2) trial: A multicenter, international, open-label, randomized controlled phase III trial of adjuvant chemotherapy versus observation in patients with adenocarcinoma of the ampulla of vater.
2011 · J. P. Neoptolemos, M. J. Moore, et al. · Journal of Clinical Oncology · 24
Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion
1999 · J.P. Stevenson, D. DeMaria, et al. · Annals of Oncology · 24
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
2001 · H.J. Mackay, A. McInnes, et al. · Annals of Oncology · 21
PDF
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer
2003 · M S Braun, F Adab, et al. · British Journal of Cancer · 16
PDF
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy
2018 · for the European Study Group for Pancreatic Cancer, N. O. Elander, et al. · British Journal of Cancer · 13
PDF
The Influence of Systemic Inflammation on Treatment Response and Survival in Anal Squamous Cell Cancer
2020 · K. Knight, J.X. Choong, et al. · Clinical Oncology · 8
Hypothyroidism Presenting with Cardiac Tamponade
1994 · J. D Quirt, A. McDonald, et al. · Scottish Medical Journal · 5
A Cancer Research UK multicenter randomized phase II study of induction chemotherapy followed by gemcitabine- or capecitabine-based chemoradiotherapy for locally advanced nonmetastatic pancreatic cancer.
2010 · S. Mukherjee, C. Hurt, et al. · Journal of Clinical Oncology · 1
85 POSTER Pharmacodynamic and efficacy relationship of MLN4924, a novel small molecule inhibitor of Nedd8-activating enzyme, in human xenograft tumors grown in immunocompromised mice
2008 · A. Berger, J. Yu, et al. · European Journal of Cancer Supplements · 1
294 Long Term Outcomes of Thoracoscopic-assisted Oesophagectomy for Early Oesophageal Cancer
2020 · A Frankel, P Lamb, et al. · Diseases of the Esophagus
A pilot study of cisplatin based combination chemotherapy in gastric cancer
1993 · A. McDonald, M. Harding, et al. · Clinical Oncology
Works count: 21
Citation count: 878
H-index: 13
I10-index: 14
Year
Topic
Type